The first real-world assessment of BBV152, a COVID-19 vaccine developed in India, suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19.
Study Reports Effectiveness of BBV152 Against COVID-19
Rochelle's Threz "R's"
I see Rochelle's Threz "R's" in your future
